Oncolytics Biotech
ONCY
#9260
Rank
NZ$0.17 B
Marketcap
NZ$1.65
Share price
-4.05%
Change (1 day)
9.42%
Change (1 year)

Oncolytics Biotech (ONCY) - Cash on Hand

Cash on Hand as of September 2025 : NZ$15.36 Million

According to Oncolytics Biotech 's latest financial reports the company has NZ$15.36 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Oncolytics Biotech - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$19.69 M-52.67%
2023-12-31NZ$41.62 M11.58%
2022-12-31NZ$37.3 M-21.3%
2021-12-31NZ$47.4 M39.69%
2020-12-31NZ$33.93 M110.97%
2019-12-31NZ$16.08 M7.28%
2018-12-31NZ$14.99 M13.11%
2017-12-31NZ$13.25 M-12.63%
2016-12-31NZ$15.17 M-44.76%
2015-12-31NZ$27.46 M54.31%
2014-12-31NZ$17.79 M-42.8%
2013-12-31NZ$31.11 M19.55%
2012-12-31NZ$26.02 M-40.71%
2011-12-31NZ$43.9 M-21.09%
2010-12-31NZ$55.63 M24.59%
2009-12-31NZ$44.65 M137.34%
2008-12-31NZ$18.81 M-42.98%
2007-12-31NZ$32.99 M-1.99%
2006-12-31NZ$33.66 M-33.7%
2005-12-31NZ$50.77 M28.3%
2004-12-31NZ$39.57 M60.81%
2003-12-31NZ$24.61 M144.52%
2002-12-31NZ$10.06 M-55.53%
2001-12-31NZ$22.63 M-14.72%
2000-12-31NZ$26.53 M339.69%
1999-12-31NZ$6.03 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Aeterna Zentaris
AEZS
NZ$48.17 M 213.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$17.17 B 111,647.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$28.58 B 185,914.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.81 B 24,732.80%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
NZ$0.13 B 772.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
NZ$1.69 B 10,906.62%๐Ÿ‡บ๐Ÿ‡ธ USA